Curcumin suppresses NTHi-induced CXCL5 expression via inhibition of positive IKKβ pathway and up-regulation of negative MKP-1 pathway

• Published in: Scientific reports Vol. 6; no. 1; p. 31695
• Main Authors: Konduru, Anuhya S., Lee, Byung-Cheol, Li, Jian-Dong
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 19.08.2016; Nature Publishing Group
• Subjects: 13; 13/106; 13/109; 13/89; 14/1; 14/63; 38/77; 38/90; 631/250/256; 631/80/86; 82; 82/29; 82/80; 96; 96/44; A549 Cells; Chemokine CXCL5 - biosynthesis; Curcumin - pharmacology; Dual Specificity Phosphatase 1 - biosynthesis; Haemophilus Infections - drug therapy; Haemophilus Infections - metabolism; Haemophilus Infections - pathology; Haemophilus influenzae - metabolism; HeLa Cells; Humanities and Social Sciences; Humans; I-kappa B Kinase - metabolism; MAP Kinase Signaling System - drug effects; multidisciplinary; p38 Mitogen-Activated Protein Kinases - metabolism; Science; Up-Regulation - drug effects
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep31695

Otitis media (OM) is the most common childhood bacterial infection and leading cause of conductive hearing loss. Nontypeable Haemophilus influenzae (NTHi) is a major bacterial pathogen for OM. OM characterized by the presence of overactive inflammatory responses is due to the aberrant production of inflammatory mediators including C-X-C motif chemokine ligand 5 (CXCL5). The molecular mechanism underlying induction of CXCL5 by NTHi is unknown. Here we show that NTHi up-regulates CXCL5 expression by activating IKKβ-IκBα and p38 MAPK pathways via NF-κB nuclear translocation-dependent and -independent mechanism in middle ear epithelial cells. Current therapies for OM are ineffective due to the emergence of antibiotic-resistant NTHi strains and risk of side effects with prolonged use of immunosuppressant drugs. In this study, we show that curcumin, derived from Curcuma longa plant, long known for its medicinal properties, inhibited NTHi-induced CXCL5 expression in vitro and in vivo . Curcumin suppressed CXCL5 expression by direct inhibition of IKKβ phosphorylation and inhibition of p38 MAPK via induction of negative regulator MKP-1. Thus, identification of curcumin as a potential therapeutic for treating OM is of particular translational significance due to the attractiveness of targeting overactive inflammation without significant adverse effects.